Add an event
Advertise / Referencing
MEDICAL SPECIALTIES > ...

MAP Molecular analysis for personalised therapy

From Friday, September, 23, 2016 to Saturday, September, 24, 2016 in London
Concerned sectors: Oncology -
DESCRIPTION
Genomic alterations – a Brave New World for cancer treatment?
New meeting on genomics in cancer treatment
The advent of genome sequencing is bringing about a quiet revolution in healthcare. Yet while the thirst for advanced genomic knowledge may seem enticing, doctors know that information without interpretation may not be very useful.

We are pleased to announce a new high-level scientific meeting that explores ways to better use existing research data in order to improve clinical oncologists’ personalised treatment programs for cancer patients.

The 2nd edition of the Molecular Analysis for Personalised therapy meeting (MAP) will be held 23-24 September in London, diving into the most pressing issues in this field.

• What are the actionable genomic alterations in frequent cancers?
• How can we define rules to identify drivers in individuals?
• What are the latest emerging technologies for personalised medicine?
• What can we learn from recent trials?

Medical oncologists, interns, academics, regulators, industry R&D reps and investigators are invited to register for this important gathering to discuss clinical interpretation of molecular tests for metastatic cancers.

A joint initiative of Cancer Research UK, UNICANCER and ESMO, this conference shines a light on the latest medical developments in a constantly evolving field.


COMMITTEES
Founders

Jean-Charles Soria, Gustave Roussy, Villejuif, France

Charles Swanton, The Francis Crick Institute, UK

Fabrice André, Gustave Roussy, Villejuif, France


Organising committee

Ian Walker, Director of Clinical Research & Strategic Partnerships, Cancer Research UK

Pascale Flamant, Déléguée générale, Fédération UNICANCER

Alessia Mora, Head of Congress Department, ESMO


Local host committee

Karen Walshe, Research Branding and Communications lead, Strategy and Research Funding, Cancer Research UK

Rosalind Onions, Project Manager International Partnerships, Strategy and Research Funding, Cancer Research UK

Hannah Henderson, Research Event Manager, Strategy and Research Funding, Cancer Research UK

Overcome agency


Scientific Committee

Charlie Swanton, The Francis Crick Institute, UK

Jean-Charles Soria, Institut Gustave Roussy, Villejuif, France

Fabrice Andre, Institut Gustave Roussy, Villejuif, France

Richard Marais, University of Manchester, UK

Alex Snyder, Memorial Sloan Kettering Cancer Centre, New York, USA

Lillian Siu, University of Toronto, Toronto, Canada

James Larkin, Institute of Cancer Research, London, UK

Jean- Yves Blay, Universite Claude Bernard, Lyon, France
PUBLIC, SECTORS, ACCREDITATION
Accreditations: 0
Concerned Public: Professional
Attendance: International
Visitors/Participants: 500
Speakers: n.c
Exhibitor: n.c
Event Type: Congress
Major Sector: ONCOLOGY
Concerned sectors: Oncology -
ORGANIZER / ADVERTISER

OVERCOME

13-15 rue des Sablons
75116 Paris
FRANCE

COMMENT
REFERENCE
Congress, conferences or medical training REF #28-6719
MAP Molecular analysis for personalised therapy
Published on congres-medical.com on:2016-05-05 14:11:18
Congress, conferences or medical training in ONCOLOGY
Visual / Poster
ONLINE HOTEL BOOKING: London
Get great deals on hotels!
near Business Design Centre

Search Hotel

Check-in date

Check-out date

VOTE
Rate for this ad
PREPARE YOUR TRIP
Exterior Sponsored Links
This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.
Plus d'information sur le HONcode